Home › Hypopharyngeal Cancer › Illinois › Cicero
Hypopharyngeal Cancer clinical trials in Cicero, IL
4 studies for Hypopharyngeal Cancer are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi away
- Advocate High Tech Medical Park, Palos Heights · 12 mi away
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Loyola University Medical Center, Maywood · 5 mi away
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi away
- Advocate High Tech Medical Park, Palos Heights · 12 mi away
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi away
Hypopharyngeal Cancer trials in other cities
- Atlanta, GA6 studies
- Chicago, IL6 studies
- Kansas City, MO5 studies
- Richmond, VA5 studies
- Stevens Point, WI5 studies
- Wausau, WI5 studies
- Milwaukee, WI5 studies
- Cape Girardeau, MO5 studies
- Peoria, IL5 studies
- Bloomington, IL5 studies
- Joliet, IL5 studies
- Kansas City, KS4 studies
Other studies in Cicero
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Prostate Cancer14 studies
- Cancer (all types)13 studies
- Breast Cancer11 studies
- Acute Myeloid Leukemia11 studies
- Colorectal Cancer10 studies
- Bladder Cancer8 studies
- Melanoma7 studies
- Cardiovascular Disease7 studies
- Metastatic Cancer7 studies
- Multiple Myeloma6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.